Literature DB >> 11091523

Tumor-associated Fever in Recurrent Breast Cancer with Liver Metastases.

.   

Abstract

Of 67 patients with recurrent breast cancer accompanied by liver metastases admitted to our facility between January 1990 and August 1993, 8(12%) were found to have tumor-associated fever. We examined the characteristics of these patents. These patients had fever (over 38 degrees C) for more than one week. Their leukocyte counts did not exceed 10000/mm(3), and C-reactive protein (CRP) was below 5 mg/dl in 6 patients. ALL 8 patients had extensive liver metastases. Six patients had massive metastatic lesions, while the remaining 2 had diffuse metastases. Following systemic chemotherapy, 3 patients showed a reduction in tumor size and remission of fever; they remain alive at 14, 16 and 19 months after treatment. Of the remaining 5 patients who did not respond to systemic chemotherapy, 4 died within 6 months. The results of this study suggest that unexplained fever in patients with recurrent breast cancer is closely related to liver metastases.

Entities:  

Year:  1994        PMID: 11091523     DOI: 10.1007/BF02967045

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  10 in total

1.  The significance of fever in neoplastic disease.

Authors:  A A BROWDER; J W HUFF; R G PETERSDORF
Journal:  Ann Intern Med       Date:  1961-12       Impact factor: 25.391

2.  Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy.

Authors:  L F FENSTER; G KLATSKIN
Journal:  Am J Med       Date:  1961-08       Impact factor: 4.965

3.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

4.  Absence of correlation between liver metastases and unexplained fever episodes.

Authors:  D Aderka; D Kidron; A Weinberger; J Pinkhas
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

5.  Fever of unexplained origin in patients with cancer.

Authors:  J Klastersky; D Weerts; C Hensgens; L Debusscher
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

6.  Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor.

Authors:  Y Matsuda; S Kawata; T Nagase; Y Maeda; E Yamasaki; S Kiso; H Ishiguro; Y Matsuzawa
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

7.  Tumor-associated fever in breast cancer.

Authors:  S P Chawla; A U Buzdar; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

8.  Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production.

Authors:  S Fukumoto; T Matsumoto; S Harada; J Fujisaki; M Kawano; E Ogata
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

9.  Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

Authors:  E Rintala; K Irjala; J Nikoskelainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

10.  Control of fever associated with visceral cancers by indomethacin.

Authors:  A L Warshaw; R W Carey; D R Robinson
Journal:  Surgery       Date:  1981-04       Impact factor: 3.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.